Regulatory Challenges Associated with RNA-Based Therapeutics
Shivani Sehta
RNA Therapeutics and the European Medicines Agency Framework RNA-based therapeutics, including mRNA vaccines, antisense oligonucleotides (ASOs), small interfering RNAs (siRNAs), and others, represent a rapidly expanding class of medicines with transformative potential for a range of diseases. However, their regulatory landscape in Europe is complex and still evolving, as highlighted by the European Public Assessment Reports (EPARs) of approved […] The post Regulatory Challenges Associated with R